UiPath (PATH) Stock Could Be 24% Undervalued After Maestro Case Launch

UiPath (PATH) is back in focus after launching Maestro Case, an AI-native case management capability that targets complex, exception-heavy workflows, with early adopters reporting sizable efficiency gains and projected cost savings.

See our latest analysis for UiPath.

Despite Maestro Case and recent customer wins such as One New Zealand Limited, short term selling pressure has left UiPath’s share price down 33.75% year to date and the 5 year total shareholder return down 84.94%. This points to fading long term momentum even as the 30 day share price return of 2.43% hints at pockets of renewed interest around AI automation catalysts.

If Maestro Case has you thinking more broadly about automation opportunities, this is a useful moment to scan other robotics and automation stocks using the Simply Wall St screener for 32 robotics and automation stocks

With UiPath stock down sharply over multi year periods, but trading at a discount to some fair value estimates and analyst targets, the key question is whether weakness has gone too far or if the market already reflects its AI automation potential.

Advertisement

Most Popular Narrative: 24% Undervalued

On the current numbers, the most followed UiPath narrative points to a fair value of $13.81, compared with the latest close of $10.52. This frames the stock as materially discounted by that framework.

UiPath's focus on accelerating innovation across the agentic automation road map is expected to grow deeper customer relationships and strategic partnerships, likely driving future revenue growth. Increased adoption of UiPath's platform among existing customers, supported by strategic changes in the go-to-market structure, is aimed at enhancing customer engagement and boosting ARR growth.

Read the complete narrative.

Curious what underpins that $13.81 fair value for UiPath stock? The narrative leans on specific revenue growth paths, margin compression, and a future earnings multiple that may surprise many readers.

Result: Fair Value of $13.81 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, UiPath stock still faces meaningful risks, including deal delays tied to geopolitics and customer budget caution, as well as SaaS transition and FX pressures on reported growth.

Find out about the key risks to this UiPath narrative.

Next Steps

With mixed sentiment around UiPath and its AI automation potential, this is a good time to review the underlying data yourself, weigh the risks against the upside, and see how the balance of 4 key rewards aligns with your own view.

Looking for more investment ideas beyond UiPath?

If you only stop at UiPath, you may miss other stocks that fit your goals, so keep your options open and keep building your watchlist.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:PATH

UiPath

Provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally.

Very undervalued with flawless balance sheet.

Advertisement

Weekly Picks

CE
Ceazar
CNXU logo
Ceazar on Conexeu Sciences ·

This small biotech is developing technology that could potentially change how tissue is rebuilt

Fair Value:US$25.3450.6% undervalued
16 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
HE
HedgeY
PWR logo
HedgeY on Quanta Services ·

The Picks-and-Shovels Leader of the Grid Supercycle

Fair Value:US$7101.3% overvalued
22 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
FU
KRMN logo
FundamentalFlow on Karman Holdings ·

KRMN — Karman Space & Defense: Down 58% from Peak, Is the Market Mispricing a Hypergrowth Defense Compounder?

Fair Value:US$105.651.0% undervalued
13 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative
DO
Double_Bubbler
IES logo
Double_Bubbler on Invinity Energy Systems ·

Invinity Energy Systems: All About That BESS

Fair Value:UK£163.7% undervalued
15 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

SI
Silvester
MDT logo
Silvester on Medtronic ·

Strong in favor of diversity in value portfolio

Fair Value:US$90.3710.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DI
NOVO B logo
Didier_Lambert_private_inv on Novo Nordisk ·

Relatively mispriced taken into account its intrinsic growth profile, providing a defensive, cash-generative entry point for investors

Fair Value:DKK 35019.9% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
GO
NLBR logo
GoranLagea on Nova Ljubljanska Banka d.d ·

Nova Ljubljanska Banka d.d. future looks bright with a profit margin change of 38%

Fair Value:€36035.0% undervalued
9 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7444.1% undervalued
66 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
HA
HarishPK
ADBE logo
HarishPK on Adobe ·

Adobe: A Probabilistic Case for Undervaluation

Fair Value:US$319.9635.2% undervalued
56 users have followed this narrative
8 users have commented on this narrative
17 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1928.3% undervalued
51 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative